TERN

Terns Pharmaceuticals, Inc.CIK 1831363 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for TERN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for TERN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Kuriakose Emil	Chief Medical Officer	18	$0	$133.3K	2026-05-05
Burroughs Amy L.	Chief Executive Officer	36	$203.3K	$6.52M	2026-05-05
Quigley Jill M.	Sr. Advisor & Strategy Officer	32	$0	$961.4K	2026-05-05
Tripuraneni Radhika	Director	14	$0	$0	2026-05-05
Azelby Robert	Director	4	$0	$0	2026-05-05
Gengos Andrew	Chief Financial Officer	12	$96.4K	$0	2026-05-05
Turner Heather D	Director	6	$0	$0	2026-05-05
KINDLER JEFFREY B	Director	17	$0	$0	2026-05-05
FELLOWS DAVID A	Director	17	$0	$0	2026-05-05
Lu Hongbo	Director	15	$23.27M	$0	2025-06-11
Jung Melita Sun	Chief Business Officer	3	$11.5K	$0	2025-01-30
Vignola Mark J.	Chief Financial Officer	15	$49.4K	$209.0K	2025-01-06
OrbiMed Genesis GP LLC	Director, 10% Owner	7	$1000.0K	$561.6K	2024-07-16
GORDON CARL L	Director, 10% Owner	26	$18.00M	$561.6K	2024-07-16
Taylor Ann Elizabeth	Director	5	$0	$0	2024-07-01
Yoon Seokho Bryan	COO and General Counsel	10	$49.4K	$0	2024-05-31
Vivo Opportunity, LLC	10% Owner	10	$2.16M	$2.80M	2024-04-03
Quirk Erin	President, Head of R&D	5	$0	$0	2024-01-23
Sundaram Senthil Vel	Chief Executive Officer	6	$14.2K	$0	2023-05-31
Vivo Opportunity Fund Holdings, L.P.	10% Owner	1	$5.50M	$0	2022-12-23
Oriental Spring Venture Ltd	10% Owner	3	$0	$8.25M	2022-11-23
OrbiMed Capital GP VII LLC	Director, 10% Owner	6	$8.93M	$0	2022-08-16
Vivo Capital Surplus Fund VIII, L.P.	10% Owner	4	$10.61M	$0	2022-08-16
Russell Kerry Strong	Chief Medical Officer	1	$0	$0	2022-07-01
Hopewell Resources Holdings Ltd	10% Owner	9	$0	$0	2021-02-09
Vivo Capital Fund VIII, L.P.	10% Owner	9	$8.07M	$0	2021-02-09
Flynn James E	10% Owner	3	$11.30M	$0	2021-02-09
ORBIMED ADVISORS LLC	Director, 10% Owner	8	$8.07M	$0	2021-02-09

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Burroughs Amy L.	Chief Executive Officer	D To issuer deriv	2026-05-05	2026-05-05	300,000	—	$0	0	SEC↗
Burroughs Amy L.	Chief Executive Officer	D To issuer deriv	2026-05-05	2026-05-05	1,250,000	—	$0	0	SEC↗
Burroughs Amy L.	Chief Executive Officer	D To issuer deriv	2026-05-05	2026-05-05	955,534	—	$0	0	SEC↗
Gengos Andrew	Chief Financial Officer	D To issuer deriv	2026-05-05	2026-05-05	137,500	—	$0	0	SEC↗
Gengos Andrew	Chief Financial Officer	D To issuer deriv	2026-05-05	2026-05-05	750,000	—	$0	0	SEC↗
Kuriakose Emil	Chief Medical Officer	D To issuer deriv	2026-05-05	2026-05-05	117,500	—	$0	0	SEC↗
Kuriakose Emil	Chief Medical Officer	D To issuer deriv	2026-05-05	2026-05-05	485,000	—	$0	0	SEC↗
Kuriakose Emil	Chief Medical Officer	D To issuer deriv	2026-05-05	2026-05-05	280,000	—	$0	0	SEC↗
Kuriakose Emil	Chief Medical Officer	D To issuer deriv	2026-05-05	2026-05-05	120,000	—	$0	0	SEC↗
Kuriakose Emil	Chief Medical Officer	D To issuer deriv	2026-05-05	2026-05-05	112,500	—	$0	0	SEC↗
FELLOWS DAVID A	Director	D To issuer deriv	2026-05-05	2026-05-05	8,183	—	$0	0	SEC↗
FELLOWS DAVID A	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
FELLOWS DAVID A	Director	D To issuer deriv	2026-05-05	2026-05-05	45,000	—	$0	0	SEC↗
FELLOWS DAVID A	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
FELLOWS DAVID A	Director	D To issuer deriv	2026-05-05	2026-05-05	22,000	—	$0	0	SEC↗
FELLOWS DAVID A	Director	D To issuer deriv	2026-05-05	2026-05-05	28,475	—	$0	0	SEC↗
FELLOWS DAVID A	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
FELLOWS DAVID A	Director	D To issuer deriv	2026-05-05	2026-05-05	2,828	—	$0	0	SEC↗
FELLOWS DAVID A	Director	D To issuer deriv	2026-05-05	2026-05-05	18,650	—	$0	0	SEC↗
KINDLER JEFFREY B	Director	D To issuer deriv	2026-05-05	2026-05-05	28,475	—	$0	0	SEC↗
KINDLER JEFFREY B	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
KINDLER JEFFREY B	Director	D To issuer deriv	2026-05-05	2026-05-05	45,000	—	$0	0	SEC↗
KINDLER JEFFREY B	Director	D To issuer deriv	2026-05-05	2026-05-05	10,657	—	$0	0	SEC↗
KINDLER JEFFREY B	Director	D To issuer deriv	2026-05-05	2026-05-05	1,697	—	$0	0	SEC↗
KINDLER JEFFREY B	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
KINDLER JEFFREY B	Director	D To issuer deriv	2026-05-05	2026-05-05	22,000	—	$0	0	SEC↗
KINDLER JEFFREY B	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
KINDLER JEFFREY B	Director	D To issuer deriv	2026-05-05	2026-05-05	4,676	—	$0	0	SEC↗
Quigley Jill M.	Director	D To issuer deriv	2026-05-05	2026-05-05	1,697	—	$0	0	SEC↗
Quigley Jill M.	Director	D To issuer deriv	2026-05-05	2026-05-05	45,000	—	$0	0	SEC↗
Quigley Jill M.	Director	D To issuer deriv	2026-05-05	2026-05-05	10,657	—	$0	0	SEC↗
Quigley Jill M.	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
Quigley Jill M.	Director	D To issuer deriv	2026-05-05	2026-05-05	3,955	—	$0	0	SEC↗
Quigley Jill M.	Director	D To issuer deriv	2026-05-05	2026-05-05	22,000	—	$0	0	SEC↗
Quigley Jill M.	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
Tripuraneni Radhika	Director	D To issuer deriv	2026-05-05	2026-05-05	1,697	—	$0	0	SEC↗
Tripuraneni Radhika	Director	D To issuer deriv	2026-05-05	2026-05-05	4,676	—	$0	0	SEC↗
Tripuraneni Radhika	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
Tripuraneni Radhika	Director	D To issuer deriv	2026-05-05	2026-05-05	32,000	—	$0	0	SEC↗
Tripuraneni Radhika	Director	D To issuer deriv	2026-05-05	2026-05-05	10,657	—	$0	0	SEC↗
Tripuraneni Radhika	Director	D To issuer deriv	2026-05-05	2026-05-05	45,000	—	$0	0	SEC↗
Tripuraneni Radhika	Director	D To issuer deriv	2026-05-05	2026-05-05	64,000	—	$0	0	SEC↗
Turner Heather D	Director	D To issuer deriv	2026-05-05	2026-05-05	1,697	—	$0	0	SEC↗
Turner Heather D	Director	D To issuer deriv	2026-05-05	2026-05-05	64,000	—	$0	0	SEC↗
Turner Heather D	Director	D To issuer deriv	2026-05-05	2026-05-05	45,000	—	$0	0	SEC↗
Azelby Robert	Director	D To issuer deriv	2026-05-05	2026-05-05	90,000	—	$0	0	SEC↗
Azelby Robert	Director	D To issuer deriv	2026-05-05	2026-05-05	1,697	—	$0	0	SEC↗
Burroughs Amy L.	Chief Executive Officer	D To issuer	2026-05-05	2026-05-05	150,000	$53.00	$7.95M	0	SEC↗
Burroughs Amy L.	Chief Executive Officer	U Tender	2026-05-05	2026-05-05	8,319	$53.00	$440.9K	0	SEC↗
Burroughs Amy L.	Chief Executive Officer	U Tender	2026-05-05	2026-05-05	146,614	$53.00	$7.77M	0	SEC↗
Gengos Andrew	Chief Financial Officer	D To issuer	2026-05-05	2026-05-05	68,750	$53.00	$3.64M	0	SEC↗
Gengos Andrew	Chief Financial Officer	U Tender	2026-05-05	2026-05-05	40,503	$53.00	$2.15M	0	SEC↗
Kuriakose Emil	Chief Medical Officer	U Tender	2026-05-05	2026-05-05	24,562	$53.00	$1.30M	0	SEC↗
Kuriakose Emil	Chief Medical Officer	D To issuer	2026-05-05	2026-05-05	81,953	$53.00	$4.34M	0	SEC↗
Kuriakose Emil	Chief Medical Officer	S Sale	2026-04-01	2026-04-02	942	$52.75	$49.7K	105,673	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise deriv	2026-03-16	2026-03-17	14,583	—	$0	955,534	SEC↗
Burroughs Amy L.	Chief Executive Officer	S Sale	2026-03-16	2026-03-17	11,813	$46.57	$550.1K	291,746	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise	2026-03-16	2026-03-17	14,583	$4.64	$67.7K	303,559	SEC↗
Burroughs Amy L.	Chief Executive Officer	S Sale	2026-03-16	2026-03-17	2,770	$47.30	$131.0K	288,976	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise deriv	2026-02-17	2026-02-18	14,583	—	$0	970,117	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise	2026-02-17	2026-02-18	14,583	$4.64	$67.7K	303,559	SEC↗
Burroughs Amy L.	Chief Executive Officer	S Sale	2026-02-17	2026-02-18	2,341	$38.07	$89.1K	301,218	SEC↗
Burroughs Amy L.	Chief Executive Officer	S Sale	2026-02-17	2026-02-18	8,159	$39.22	$320.0K	293,059	SEC↗
Burroughs Amy L.	Chief Executive Officer	S Sale	2026-02-17	2026-02-18	4,083	$39.80	$162.5K	288,976	SEC↗
FELLOWS DAVID A	Director	A Award deriv	2026-02-01	2026-02-02	2,828	—	$0	2,828	SEC↗
KINDLER JEFFREY B	Director	A Award deriv	2026-02-01	2026-02-02	1,697	—	$0	1,697	SEC↗
Quigley Jill M.	Director	A Award deriv	2026-02-01	2026-02-02	1,697	—	$0	1,697	SEC↗
Azelby Robert	Director	A Award deriv	2026-02-01	2026-02-02	1,697	—	$0	1,697	SEC↗
Tripuraneni Radhika	Director	A Award deriv	2026-02-01	2026-02-02	1,697	—	$0	1,697	SEC↗
Turner Heather D	Director	A Award deriv	2026-02-01	2026-02-02	1,697	—	$0	1,697	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise deriv	2026-01-15	2026-01-16	27,083	—	$0	1,026,366	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise deriv	2026-01-15	2026-01-16	27,083	—	$0	999,283	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise deriv	2026-01-15	2026-01-16	14,583	—	$0	984,700	SEC↗
Burroughs Amy L.	Chief Executive Officer	S Sale	2026-01-15	2026-01-16	7,521	$37.53	$282.3K	288,976	SEC↗
Burroughs Amy L.	Chief Executive Officer	S Sale	2026-01-15	2026-01-16	61,228	$37.02	$2.27M	296,497	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise	2026-01-15	2026-01-16	14,583	$4.64	$67.7K	357,725	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise	2026-01-15	2026-01-16	27,083	$4.64	$125.7K	343,142	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise	2026-01-15	2026-01-16	27,083	$4.64	$125.7K	316,059	SEC↗
Burroughs Amy L.	Chief Executive Officer	A Award deriv	2026-01-14	2026-01-16	300,000	—	$0	300,000	SEC↗
Gengos Andrew	Chief Financial Officer	A Award deriv	2026-01-14	2026-01-16	137,500	—	$0	137,500	SEC↗
Kuriakose Emil	Chief Medical Officer	A Award deriv	2026-01-14	2026-01-16	112,500	—	$0	112,500	SEC↗
Burroughs Amy L.	Chief Executive Officer	A Award	2026-01-14	2026-01-16	150,000	—	$0	288,976	SEC↗
Gengos Andrew	Chief Financial Officer	A Award	2026-01-14	2026-01-16	68,750	—	$0	101,788	SEC↗
Kuriakose Emil	Chief Medical Officer	A Award	2026-01-14	2026-01-16	56,250	—	$0	106,615	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise deriv	2026-01-05	2026-01-06	150,000	—	$0	0	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise	2026-01-05	2026-01-06	150,000	—	$0	210,315	SEC↗
Burroughs Amy L.	Chief Executive Officer	S Sale	2026-01-05	2026-01-06	71,339	$38.10	$2.72M	138,976	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise deriv	2026-01-02	2026-01-06	21,551	—	$0	1,053,449	SEC↗
Kuriakose Emil	Chief Medical Officer	S Sale	2026-01-02	2026-01-06	200	$39.60	$7.9K	51,320	SEC↗
Kuriakose Emil	Chief Medical Officer	S Sale	2026-01-02	2026-01-06	955	$38.36	$36.6K	50,365	SEC↗
Burroughs Amy L.	Chief Executive Officer	M Exercise	2026-01-02	2026-01-06	21,551	$4.64	$100.0K	60,315	SEC↗
Quigley Jill M.	Director	M Exercise deriv	2025-11-04	2025-11-05	24,520	—	$0	3,955	SEC↗
Quigley Jill M.	Director	M Exercise	2025-11-04	2025-11-05	24,520	$9.24	$226.6K	24,520	SEC↗
Quigley Jill M.	Director	S Sale	2025-11-04	2025-11-05	24,520	$18.00	$441.4K	0	SEC↗
Kuriakose Emil	Chief Medical Officer	S Sale	2025-10-01	2025-10-02	944	$7.85	$7.4K	51,520	SEC↗
Kuriakose Emil	Chief Medical Officer	S Sale	2025-07-01	2025-07-03	853	$4.27	$3.6K	52,464	SEC↗
Gengos Andrew	Chief Financial Officer	P Buy	2025-06-27	2025-06-30	5,000	$3.93	$19.6K	20,000	SEC↗
Gengos Andrew	Chief Financial Officer	P Buy	2025-06-27	2025-06-30	5,000	$3.93	$19.6K	25,000	SEC↗
Burroughs Amy L.	Chief Executive Officer	P Buy	2025-06-25	2025-06-25	23,314	$3.87	$90.2K	47,083	SEC↗
Gengos Andrew	Chief Financial Officer	P Buy	2025-06-16	2025-06-16	5,000	$3.95	$19.8K	15,000	SEC↗
Gengos Andrew	Chief Financial Officer	P Buy	2025-06-13	2025-06-16	5,000	$3.72	$18.6K	10,000	SEC↗
Gengos Andrew	Chief Financial Officer	P Buy	2025-06-13	2025-06-16	5,000	$3.75	$18.8K	5,000	SEC↗
FELLOWS DAVID A	Director	A Award deriv	2025-06-11	2025-06-12	45,000	—	$0	45,000	SEC↗
Quigley Jill M.	Director	A Award deriv	2025-06-11	2025-06-12	45,000	—	$0	45,000	SEC↗
Turner Heather D	Director	A Award deriv	2025-06-11	2025-06-12	45,000	—	$0	45,000	SEC↗
KINDLER JEFFREY B	Director	A Award deriv	2025-06-11	2025-06-12	45,000	—	$0	45,000	SEC↗
Lu Hongbo	Director	A Award deriv	2025-06-11	2025-06-12	45,000	—	$0	45,000	SEC↗
Tripuraneni Radhika	Director	A Award deriv	2025-06-11	2025-06-12	45,000	—	$0	45,000	SEC↗
Kuriakose Emil	Chief Medical Officer	S Sale	2025-04-01	2025-04-02	952	$2.49	$2.4K	53,317	SEC↗
Gengos Andrew	Chief Financial Officer	A Award deriv	2025-02-24	2025-02-25	750,000	—	$0	750,000	SEC↗
Azelby Robert	Director	A Award deriv	2025-02-20	2025-02-24	90,000	—	$0	90,000	SEC↗
FELLOWS DAVID A	Director	A Award deriv	2025-02-01	2025-02-03	18,650	—	$0	18,650	SEC↗
KINDLER JEFFREY B	Director	A Award deriv	2025-02-01	2025-02-03	10,657	—	$0	10,657	SEC↗
Quigley Jill M.	Director	A Award deriv	2025-02-01	2025-02-03	10,657	—	$0	10,657	SEC↗
Tripuraneni Radhika	Director	A Award deriv	2025-02-01	2025-02-03	10,657	—	$0	10,657	SEC↗
Lu Hongbo	Director	A Award deriv	2025-02-01	2025-02-03	10,657	—	$0	10,657	SEC↗
Burroughs Amy L.	Chief Executive Officer	A Award deriv	2025-01-30	2025-02-03	1,075,000	—	$0	1,075,000	SEC↗
Kuriakose Emil	Chief Medical Officer	A Award deriv	2025-01-30	2025-02-03	485,000	—	$0	485,000	SEC↗
Jung Melita Sun	Chief Business Officer	A Award deriv	2025-01-30	2025-02-03	325,000	—	$0	325,000	SEC↗
Quigley Jill M.	Director	S Sale	2025-01-06	2025-01-06	8,760	$5.79	$50.7K	0	SEC↗
Vignola Mark J.	Chief Financial Officer	S Sale	2025-01-06	2025-01-06	9,059	$5.80	$52.5K	74,752	SEC↗
Quigley Jill M.	Director	S Sale	2025-01-02	2025-01-06	6,240	$5.72	$35.7K	8,760	SEC↗
Vignola Mark J.	Chief Financial Officer	S Sale	2025-01-02	2025-01-06	8,129	$5.72	$46.5K	83,811	SEC↗
Kuriakose Emil	Chief Medical Officer	S Sale	2025-01-02	2025-01-06	4,481	$5.71	$25.6K	54,269	SEC↗
Kuriakose Emil	Chief Medical Officer	A Award deriv	2024-12-12	2024-12-16	120,000	—	$0	120,000	SEC↗
Burroughs Amy L.	Chief Executive Officer	P Buy	2024-12-05	2024-12-09	15,450	$7.15	$110.5K	19,099	SEC↗
Burroughs Amy L.	Chief Executive Officer	P Buy	2024-11-30	2025-02-03	510	$5.11	$2.6K	19,609	SEC↗
Jung Melita Sun	Chief Business Officer	P Buy	2024-11-30	2025-02-03	2,250	$5.11	$11.5K	2,250	SEC↗
Turner Heather D	Director	A Award deriv	2024-11-18	2024-11-19	64,000	—	$0	64,000	SEC↗
Lu Hongbo	Director	P Buy	2024-09-12	2024-09-17	190,476	$10.50	$2.00M	190,476	SEC↗
Lu Hongbo	Director	P Buy	2024-09-12	2024-09-17	285,714	$10.50	$3.00M	476,190	SEC↗
Vignola Mark J.	Chief Financial Officer	M Exercise deriv	2024-09-10	2024-09-12	10,000	—	$0	55,000	SEC↗
Vignola Mark J.	Chief Financial Officer	S Sale	2024-09-10	2024-09-12	10,000	$11.00	$110.0K	91,940	SEC↗
Vignola Mark J.	Chief Financial Officer	M Exercise	2024-09-10	2024-09-12	10,000	$5.36	$53.6K	101,940	SEC↗
Quigley Jill M.	Director	M Exercise deriv	2024-09-09	2024-09-11	17,235	—	$0	0	SEC↗
Quigley Jill M.	Director	M Exercise	2024-09-09	2024-09-11	17,235	$1.82	$31.4K	32,235	SEC↗
Quigley Jill M.	Director	S Sale	2024-09-09	2024-09-11	17,235	$10.00	$172.3K	15,000	SEC↗
Quigley Jill M.	Director	S Sale	2024-08-02	2024-08-05	8,857	$7.50	$66.4K	15,000	SEC↗
Quigley Jill M.	Director	S Sale	2024-08-01	2024-08-05	6,143	$7.68	$47.2K	23,857	SEC↗
Quigley Jill M.	Director	M Exercise deriv	2024-07-16	2024-07-17	400	—	$0	17,235	SEC↗
Quigley Jill M.	Director	S Sale	2024-07-16	2024-07-17	400	$10.00	$4.0K	30,000	SEC↗
Quigley Jill M.	Director	M Exercise	2024-07-16	2024-07-17	400	$1.82	$728	30,400	SEC↗
OrbiMed Genesis GP LLC	Director, 10% Owner	S Sale	2024-07-16	2024-07-17	556	$10.00	$5.6K	1,967,924	SEC↗
OrbiMed Genesis GP LLC	Director, 10% Owner	S Sale	2024-07-16	2024-07-17	4,009	$10.00	$40.1K	4,839,412	SEC↗
OrbiMed Genesis GP LLC	Director, 10% Owner	S Sale	2024-07-16	2024-07-17	623	$10.00	$6.2K	755,635	SEC↗
GORDON CARL L	Director, 10% Owner	S Sale	2024-07-16	2024-07-17	556	$10.00	$5.6K	1,967,924	SEC↗
GORDON CARL L	Director, 10% Owner	S Sale	2024-07-16	2024-07-17	623	$10.00	$6.2K	755,635	SEC↗
GORDON CARL L	Director, 10% Owner	S Sale	2024-07-16	2024-07-17	4,009	$10.00	$40.1K	4,839,412	SEC↗
Quigley Jill M.	Director	M Exercise deriv	2024-07-15	2024-07-17	14,365	—	$0	17,635	SEC↗
Quigley Jill M.	Director	S Sale	2024-07-15	2024-07-17	14,365	$10.00	$143.7K	30,000	SEC↗
Quigley Jill M.	Director	M Exercise	2024-07-15	2024-07-17	14,365	$1.82	$26.1K	44,365	SEC↗
OrbiMed Genesis GP LLC	Director, 10% Owner	S Sale	2024-07-15	2024-07-17	39,433	$10.00	$394.3K	4,843,421	SEC↗
OrbiMed Genesis GP LLC	Director, 10% Owner	S Sale	2024-07-15	2024-07-17	5,401	$10.00	$54.0K	1,968,480	SEC↗
OrbiMed Genesis GP LLC	Director, 10% Owner	S Sale	2024-07-15	2024-07-17	6,142	$10.00	$61.4K	756,258	SEC↗
GORDON CARL L	Director, 10% Owner	S Sale	2024-07-15	2024-07-17	6,142	$10.00	$61.4K	756,258	SEC↗
GORDON CARL L	Director, 10% Owner	S Sale	2024-07-15	2024-07-17	5,401	$10.00	$54.0K	1,968,480	SEC↗
GORDON CARL L	Director, 10% Owner	S Sale	2024-07-15	2024-07-17	39,433	$10.00	$394.3K	4,843,421	SEC↗
FELLOWS DAVID A	Director	A Award deriv	2024-07-01	2024-07-02	8,183	—	$0	8,183	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2024-07-01	2024-07-02	4,676	—	$0	4,676	SEC↗
KINDLER JEFFREY B	Director	A Award deriv	2024-07-01	2024-07-02	4,676	—	$0	4,676	SEC↗
Lu Hongbo	Director	A Award deriv	2024-07-01	2024-07-02	4,676	—	$0	4,676	SEC↗
Taylor Ann Elizabeth	Director	A Award deriv	2024-07-01	2024-07-02	4,676	—	$0	4,676	SEC↗
Tripuraneni Radhika	Director	A Award deriv	2024-07-01	2024-07-02	4,676	—	$0	4,676	SEC↗
FELLOWS DAVID A	Director	A Award deriv	2024-06-10	2024-06-14	32,000	—	$0	32,000	SEC↗
KINDLER JEFFREY B	Director	A Award deriv	2024-06-10	2024-06-14	32,000	—	$0	32,000	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2024-06-10	2024-06-14	32,000	—	$0	32,000	SEC↗
Quigley Jill M.	Director	A Award deriv	2024-06-10	2024-06-14	32,000	—	$0	32,000	SEC↗
Lu Hongbo	Director	A Award deriv	2024-06-10	2024-06-14	32,000	—	$0	32,000	SEC↗
Taylor Ann Elizabeth	Director	A Award deriv	2024-06-10	2024-06-14	32,000	—	$0	32,000	SEC↗
Tripuraneni Radhika	Director	A Award deriv	2024-06-10	2024-06-14	32,000	—	$0	32,000	SEC↗
Vignola Mark J.	Chief Financial Officer	P Buy	2024-05-31	2024-06-04	4,791	$4.44	$21.3K	91,940	SEC↗
Yoon Seokho Bryan	COO and General Counsel	P Buy	2024-05-31	2024-06-04	4,791	$4.44	$21.3K	91,940	SEC↗
Jung Melita Sun	Chief Business Officer	A Award deriv	2024-05-01	2024-05-02	475,000	—	$0	475,000	SEC↗
Vivo Opportunity, LLC	10% Owner	S Sale	2024-04-03	2024-04-03	4,149	$6.20	$25.7K	268,573	SEC↗
Vivo Opportunity, LLC	10% Owner	S Sale	2024-04-03	2024-04-03	30,047	$6.20	$186.3K	1,945,015	SEC↗
Vivo Opportunity, LLC	10% Owner	S Sale	2024-04-03	2024-04-03	103,870	$6.20	$644.0K	4,023,741	SEC↗
Vivo Opportunity, LLC	10% Owner	S Sale	2024-04-02	2024-04-03	76,346	$6.65	$507.7K	4,127,611	SEC↗
Vivo Opportunity, LLC	10% Owner	S Sale	2024-04-02	2024-04-03	3,050	$6.65	$20.3K	272,722	SEC↗
Vivo Opportunity, LLC	10% Owner	S Sale	2024-04-02	2024-04-03	22,084	$6.65	$146.9K	1,975,062	SEC↗
Vivo Opportunity, LLC	10% Owner	S Sale	2024-04-01	2024-04-03	136,255	$6.99	$952.4K	4,203,957	SEC↗
Vivo Opportunity, LLC	10% Owner	S Sale	2024-04-01	2024-04-03	39,411	$6.99	$275.5K	1,997,146	SEC↗
Vivo Opportunity, LLC	10% Owner	S Sale	2024-04-01	2024-04-03	5,451	$6.99	$38.1K	275,772	SEC↗
Burroughs Amy L.	Chief Executive Officer	A Award deriv	2024-03-01	2024-03-05	1,250,000	—	$0	1,250,000	SEC↗
Burroughs Amy L.	Chief Executive Officer	A Award deriv	2024-03-01	2024-03-05	150,000	—	$0	150,000	SEC↗
Quirk Erin	President, Head of R&D	A Award deriv	2024-01-23	2024-01-25	150,000	—	$0	150,000	SEC↗
Vignola Mark J.	Chief Financial Officer	A Award deriv	2024-01-23	2024-01-25	137,500	—	$0	137,500	SEC↗
Yoon Seokho Bryan	COO and General Counsel	A Award deriv	2024-01-23	2024-01-25	137,500	—	$0	137,500	SEC↗
Quirk Erin	President, Head of R&D	A Award	2024-01-23	2024-01-25	75,000	—	$0	75,000	SEC↗
Vignola Mark J.	Chief Financial Officer	A Award	2024-01-23	2024-01-25	68,750	—	$0	87,149	SEC↗
Yoon Seokho Bryan	COO and General Counsel	A Award	2024-01-23	2024-01-25	68,750	—	$0	87,149	SEC↗
Quigley Jill M.	Sr. Advisor & Strategy Offic	A Award	2024-01-23	2024-01-25	15,000	—	$0	30,000	SEC↗
Vignola Mark J.	Chief Financial Officer	P Buy	2023-11-30	2023-12-04	743	$3.78	$2.8K	18,399	SEC↗
Yoon Seokho Bryan	COO and General Counsel	P Buy	2023-11-30	2023-12-04	743	$3.78	$2.8K	18,399	SEC↗
Quigley Jill M.	Sr. Advisor & Strategy Offic	A Award	2023-11-15	2023-11-17	15,000	—	$0	15,000	SEC↗
KINDLER JEFFREY B	Director	A Award deriv	2023-06-12	2023-06-14	32,000	—	$0	32,000	SEC↗
Lu Hongbo	Director	A Award deriv	2023-06-12	2023-06-14	32,000	—	$0	32,000	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2023-06-12	2023-06-14	32,000	—	$0	32,000	SEC↗
FELLOWS DAVID A	Director	A Award deriv	2023-06-12	2023-06-14	32,000	—	$0	32,000	SEC↗
Quigley Jill M.	Director	A Award deriv	2023-06-12	2023-06-14	32,000	—	$0	32,000	SEC↗
Tripuraneni Radhika	Director	A Award deriv	2023-06-12	2023-06-14	32,000	—	$0	32,000	SEC↗
Taylor Ann Elizabeth	Director	A Award deriv	2023-06-12	2023-06-14	32,000	—	$0	32,000	SEC↗
Sundaram Senthil Vel	Chief Executive Officer	P Buy	2023-05-31	2023-06-02	2,111	$1.41	$3.0K	9,770	SEC↗
Yoon Seokho Bryan	COO and General Counsel	P Buy	2023-05-31	2023-06-02	9,997	$1.41	$14.1K	17,656	SEC↗
Vignola Mark J.	Chief Financial Officer	P Buy	2023-05-31	2023-06-02	9,997	$1.41	$14.1K	17,656	SEC↗
Sundaram Senthil Vel	Chief Executive Officer	A Award deriv	2023-02-01	2023-02-03	900,000	—	$0	900,000	SEC↗
Quirk Erin	President, Head of R&D	A Award deriv	2023-02-01	2023-02-03	600,000	—	$0	600,000	SEC↗
Vignola Mark J.	Chief Financial Officer	A Award deriv	2023-02-01	2023-02-03	360,000	—	$0	360,000	SEC↗
Yoon Seokho Bryan	COO and General Counsel	A Award deriv	2023-02-01	2023-02-03	360,000	—	$0	360,000	SEC↗
Lu Hongbo	Director	P Buy	2022-12-23	2022-12-23	758,620	$7.25	$5.50M	4,340,212	SEC↗
Vivo Opportunity Fund Holdings	10% Owner	P Buy	2022-12-23	2022-12-23	758,620	$7.25	$5.50M	4,340,212	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-12-23	2022-12-28	137,931	$7.25	$1000.0K	4,882,854	SEC↗
OrbiMed Genesis GP LLC	Director, 10% Owner	P Buy	2022-12-23	2022-12-28	137,931	$7.25	$1000.0K	4,882,854	SEC↗
Sundaram Senthil Vel	Chief Executive Officer	P Buy	2022-11-30	2023-02-03	3	$1.41	$4	7,659	SEC↗
Vignola Mark J.	Chief Financial Officer	P Buy	2022-11-30	2023-02-03	3	$1.41	$4	7,659	SEC↗
Yoon Seokho Bryan	COO and General Counsel	P Buy	2022-11-30	2023-02-03	3	$1.41	$4	7,659	SEC↗
Oriental Spring Venture Ltd	10% Owner	S Sale	2022-11-23	2022-11-28	166,666	$5.50	$916.7K	529,762	SEC↗
Oriental Spring Venture Ltd	10% Owner	S Sale	2022-11-23	2022-11-28	333,334	$5.50	$1.83M	1,059,523	SEC↗
Oriental Spring Venture Ltd	10% Owner	S Sale	2022-11-23	2022-11-28	1,000,000	$5.50	$5.50M	405,583	SEC↗
Lu Hongbo	Director	P Buy	2022-09-07	2022-09-08	600,000	$3.60	$2.16M	3,581,592	SEC↗
Vivo Opportunity, LLC	10% Owner	P Buy	2022-09-07	2022-09-08	600,000	$3.60	$2.16M	3,581,592	SEC↗
Lu Hongbo	Director	P Buy deriv	2022-08-16	2022-08-16	1,500,000	$2.42	$3.63M	1,500,000	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	P Buy deriv	2022-08-16	2022-08-16	1,500,000	$2.42	$3.63M	1,500,000	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy deriv	2022-08-16	2022-08-18	64,050	—	$0	64,050	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy deriv	2022-08-16	2022-08-18	207,500	—	$0	207,500	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy deriv	2022-08-16	2022-08-18	38,450	—	$0	38,450	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy deriv	2022-08-16	2022-08-18	38,450	—	$0	38,450	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy deriv	2022-08-16	2022-08-18	207,500	—	$0	207,500	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy deriv	2022-08-16	2022-08-18	64,050	—	$0	64,050	SEC↗
Lu Hongbo	Director	P Buy	2022-08-16	2022-08-16	1,500,000	$2.42	$3.63M	2,981,592	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	P Buy	2022-08-16	2022-08-16	1,500,000	$2.42	$3.63M	2,981,592	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-08-16	2022-08-18	457,400	$2.42	$1.11M	1,973,881	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-08-16	2022-08-18	2,470,200	$2.42	$5.98M	4,744,923	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2022-08-16	2022-08-18	762,400	$2.42	$1.85M	762,400	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-08-16	2022-08-18	457,400	$2.42	$1.11M	1,973,881	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-08-16	2022-08-18	762,400	$2.42	$1.85M	762,400	SEC↗
OrbiMed Capital GP VII LLC	Director, 10% Owner	P Buy	2022-08-16	2022-08-18	2,470,200	$2.42	$5.98M	4,744,923	SEC↗
Lu Hongbo	Director	P Buy	2022-08-15	2022-08-16	1,218	$2.99	$3.6K	1,481,592	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	P Buy	2022-08-15	2022-08-16	1,218	$2.99	$3.6K	1,481,592	SEC↗
Lu Hongbo	Director	P Buy	2022-08-12	2022-08-16	1,123,021	$2.98	$3.35M	1,480,374	SEC↗
Vivo Capital Surplus Fund VIII	10% Owner	P Buy	2022-08-12	2022-08-16	1,123,021	$2.98	$3.35M	1,480,374	SEC↗
Tripuraneni Radhika	Director	A Award deriv	2022-07-26	2022-07-28	64,000	—	$0	64,000	SEC↗
Russell Kerry Strong	Chief Medical Officer	A Award deriv	2022-07-01	2022-07-06	240,000	—	$0	240,000	SEC↗
KINDLER JEFFREY B	Director	A Award deriv	2022-06-16	2022-06-21	32,000	—	$0	32,000	SEC↗
Lu Hongbo	Director	A Award deriv	2022-06-16	2022-06-21	32,000	—	$0	32,000	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2022-06-16	2022-06-21	32,000	—	$0	32,000	SEC↗
FELLOWS DAVID A	Director	A Award deriv	2022-06-16	2022-06-21	32,000	—	$0	32,000	SEC↗
Quigley Jill M.	Director	A Award deriv	2022-06-16	2022-06-21	32,000	—	$0	32,000	SEC↗
Taylor Ann Elizabeth	Director	A Award deriv	2022-06-16	2022-06-21	32,000	—	$0	32,000	SEC↗
Sundaram Senthil Vel	Chief Executive Officer	P Buy	2022-05-31	2022-06-08	7,656	$1.47	$11.3K	7,656	SEC↗
Vignola Mark J.	Chief Financial Officer	P Buy	2022-05-31	2022-06-08	7,656	$1.47	$11.3K	7,656	SEC↗
Yoon Seokho Bryan	COO and General Counsel	P Buy	2022-05-31	2022-06-08	7,656	$1.47	$11.3K	7,656	SEC↗
Sundaram Senthil Vel	Chief Executive Officer	A Award deriv	2022-01-26	2022-01-28	280,000	—	$0	280,000	SEC↗
Yoon Seokho Bryan	COO and General Counsel	A Award deriv	2022-01-26	2022-01-28	65,000	—	$0	65,000	SEC↗
Vignola Mark J.	Chief Financial Officer	A Award deriv	2022-01-26	2022-01-28	65,000	—	$0	65,000	SEC↗
Quirk Erin	President, CMO and Head of R	A Award deriv	2022-01-26	2022-01-28	92,500	—	$0	92,500	SEC↗
Taylor Ann Elizabeth	Director	A Award deriv	2021-09-28	2021-10-12	44,000	—	$0	44,000	SEC↗
FELLOWS DAVID A	Director	A Award deriv	2021-09-28	2021-09-30	22,000	—	$0	22,000	SEC↗
Quigley Jill M.	Director	A Award deriv	2021-09-28	2021-09-30	22,000	—	$0	22,000	SEC↗
Sundaram Senthil Vel	Chief Executive Officer	A Award deriv	2021-09-28	2021-09-30	315,000	—	$0	315,000	SEC↗
Quirk Erin	President and CMO	A Award deriv	2021-09-28	2021-09-30	142,500	—	$0	142,500	SEC↗
KINDLER JEFFREY B	Director	A Award deriv	2021-09-28	2021-09-30	22,000	—	$0	22,000	SEC↗
Vignola Mark J.	Chief Financial Officer	A Award deriv	2021-09-28	2021-09-30	120,000	—	$0	120,000	SEC↗
Yoon Seokho Bryan	COO and General Counsel	A Award deriv	2021-09-28	2021-09-30	120,000	—	$0	120,000	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2021-02-24	2021-02-26	25,000	—	$0	25,000	SEC↗
Lu Hongbo	Director	A Award deriv	2021-02-24	2021-02-26	25,000	—	$0	25,000	SEC↗
Flynn James E	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	1,717,033	—	$0	0	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	364,138	—	$0	0	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	98,484	—	$0	0	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	713,203	—	$0	0	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	50,282	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion deriv	2021-02-09	2021-02-09	918,295	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion deriv	2021-02-09	2021-02-09	714,285	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion deriv	2021-02-09	2021-02-09	1,071,428	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion deriv	2021-02-09	2021-02-09	612,196	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2021-02-09	2021-02-09	714,285	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2021-02-09	2021-02-09	918,295	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2021-02-09	2021-02-09	1,071,428	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2021-02-09	2021-02-09	612,196	—	$0	0	SEC↗
Hopewell Resources Holdings Lt	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	1,405,583	—	$0	0	SEC↗
Hopewell Resources Holdings Lt	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	1,392,857	—	$0	0	SEC↗
Hopewell Resources Holdings Lt	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	334,318	—	$0	0	SEC↗
Hopewell Resources Holdings Lt	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	696,428	—	$0	0	SEC↗
Hopewell Resources Holdings Lt	10% Owner	C Conversion deriv	2021-02-09	2021-02-09	952,380	—	$0	0	SEC↗
Flynn James E	10% Owner	P Buy	2021-02-09	2021-02-09	665,000	$17.00	$11.30M	2,382,033	SEC↗
Flynn James E	10% Owner	C Conversion	2021-02-09	2021-02-09	1,717,033	—	$0	1,717,033	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	P Buy	2021-02-09	2021-02-09	357,353	$17.00	$6.08M	357,353	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	P Buy	2021-02-09	2021-02-09	14,275	$17.00	$242.7K	281,223	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion	2021-02-09	2021-02-09	266,948	—	$0	266,948	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	C Conversion	2021-02-09	2021-02-09	1,933,185	—	$0	1,933,185	SEC↗
Vivo Capital Fund VIII, L.P.	10% Owner	P Buy	2021-02-09	2021-02-09	103,372	$17.00	$1.76M	2,036,557	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion	2021-02-09	2021-02-09	1,989,723	—	$0	1,989,723	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion	2021-02-09	2021-02-09	1,326,481	—	$0	1,326,481	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2021-02-09	2021-02-09	190,000	$17.00	$3.23M	1,516,481	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2021-02-09	2021-02-09	285,000	$17.00	$4.84M	2,274,723	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2021-02-09	2021-02-09	285,000	$17.00	$4.84M	2,274,723	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion	2021-02-09	2021-02-09	1,989,723	—	$0	1,989,723	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion	2021-02-09	2021-02-09	1,326,481	—	$0	1,326,481	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2021-02-09	2021-02-09	190,000	$17.00	$3.23M	1,516,481	SEC↗
Hopewell Resources Holdings Lt	10% Owner	C Conversion	2021-02-09	2021-02-09	1,392,857	—	$0	1,392,857	SEC↗
Hopewell Resources Holdings Lt	10% Owner	C Conversion	2021-02-09	2021-02-09	1,286,698	—	$0	1,286,698	SEC↗